Naoki Furuya

27PUBLICATIONS
140CO-AUTHORS
Liquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsElectrical energy transmission, networks and systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 29, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

|Feb 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.0.

Joshua E Reuss, Lyudmila Bazhenova, Nofisat Ismaila

|Feb 03, 2026
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.0.

Sonam Puri, Natasha B Leighl, Nofisat Ismaila

|Dec 11, 2025
Immune checkpoint inhibitors for advanced non-small cell lung cancer with poor performance status or older patients.

Naoki Furuya

|Aug 22, 2025
<i>EGFR</i> Exon 20 insertions in NSCLC: from biology to amivantamab, optimal treatment strategy and emerging therapeutics.

Naoki Furuya

|Jul 17, 2025
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2025.1.

Joshua E Reuss, Sara Kuruvilla, Nofisat Ismaila

Pageof 5

Frequent Collaborators

6 joint publications

Natasha B Leighl

6 joint publications

Ibrahim Hanna Azar

6 joint publications

Nofisat Ismaila

5 joint publications

Joshua E Reuss